Amarin Corp Plc (AMRN)

[Biobillionair]

Raf- GILD, PFE, JPM and Jan 17th call volume. PFE dumps NASH drug, GILD adds Vascepa to clinical trial.

Articles combining PFE and GILD with large M&A...


So what’s holding back Pfizer and Gilead from the really big M&A deals we’ve all been waiting for?
https://endpts.com/so-whats-holding-back-pfizer-and-gilead-from-the-really-big-ma-deals-weve-all-been-waiting-for/

Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way
https://www.bloomberg.com/news/articles/2019-01-07/gilead-pfizer-execs-suggest-even-more-pharma-m-a-is-on-the-way

12-3 Combo drug patent with detailed Pfizer compounds...

4. The method of claim 1 wherein the hydroxy-derivative of a statin or pharmaceutically acceptable salt thereof is selected from o-hydroxy atorvastatin, p-hydroxy atorvastatin, p-hydroxy atorvastatin calcium, p-hydroxy atorvastatin disodium, o-hydroxy atorvastatin calcium, o-hydroxy atorvastatin lactone, o-hydroxy atorvastatin-d5 calcium, o-hydroxy atorvastatin-d5 disodium, o-hydroxy atorvastatin-d5 lactone, 2-hydroxy atorvastatin bisodium, p-hydroxy atorvastatin lactone, p-hydroxy atorvastatin-d5 calcium, p-hydroxy atorvastatin-d5 lactone, and 4-hydroxy atorvastatin bisodium.

You know I’m on to something...

BB